Trial Profile
Effect of low-dose HPV16 synthetic long-peptide vaccine (HPV16-SLP) in patients with low-grade cervical squamous intraepithelial lesions (LSIL)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs ISA 101 (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Pharmacodynamics
- 12 Dec 2015 New trial record